Clearside Biomedical, GA Tech venture spin-out, lands $7.9M investment
Clearside Biomedical, Inc. an Atlanta-based ophthalmic pharmaceutical company launched from research at Emory University and the Georgia Institute of Technology, has received $7.9 million in funding to continue drug and technology development for treatment of ocular diseases. The new funding is in addition to a $4 million venture capital investment received by Clearside Biomedical in […]